Silexion Therapeutics Corp - Ordinary Shares (SLXN)

Silexion Therapeutics Corp is a biotechnology company focused on developing innovative therapies to address unmet medical needs in various therapeutic areas

The company specializes in the discovery and advancement of novel drug candidates utilizing its proprietary technologies. With a commitment to improving patient outcomes, Silexion aims to leverage cutting-edge research and development to create targeted treatments that enhance the quality of life for individuals suffering from complex diseases. Through collaboration with academic institutions and industry partners, Silexion strives to bring transformative healthcare solutions to market.